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Abstract
Mycetoma is a persistent, progressive granulomatous inflammatory disease caused either
by fungi or by bacteria. Characteristic of this disease is that the causative agents organise
themselves in macroscopic structures called grains. These grains are surrounded by a
massive inflammatory reaction. The processes leading to this host tissue reaction and the
immunophenotypic characteristics of the mycetoma granuloma are not known. Due to the
massive immune reaction and the tissue remodeling involved, we hypothesised that the
expression levels of interleukin-17 (IL-17) and matrix metalloprotease-9 (MMP-9) in the
mycetoma granuloma formation were correlated to the severity of the disease and that this
correlation was independent of the causative agent responsible for the granuloma reaction.
To determine the expression of IL-17 and MMP-9 in mycetoma lesions, the present study
was conducted at the Mycetoma Research Centre, Sudan. Surgical biopsies from 100
patients with confirmed mycetoma were obtained, and IL-17 and MMP-9 expression in the
mycetoma granuloma were evaluated immunohistochemically. IL-17 was mainly expressed
in Zones I and II, and far less in Zone III. MMP-9 was detected mainly in Zones II and III, and
the least expression was in Zone I. MMP-9 was more highly expressed in Actinomadura pel-
letierii and Streptomyces somaliensis biopsies compared to Madurella mycetomatis biop-
sies. MMP-9 levels were directly proportional to the levels of IL-17 (p = 0.001). The only
significant association between MMP9 and the patients’ characteristics was the disease
duration (p<0.001). There was an insignificant correlation between the IL-17 levels and the
patients’ demographic characteristics.
Author summary
Mycetoma is a progressive and destructive, chronic granulomatous tumourous inflamma-
tory disease, which is caused by a wide range of bacterial and fungal organisms. These
causative agents form grains inside the tissue and a large inflammation zone and collagen
capsule is found to be surrounding them. How these grains and the surrounding tissue
reaction are formed is currently not known. In this study we demonstrated that IL-17A
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and MMP-9 were expressed in the mycetoma granuloma but at different zones surround-
ing the grain. The MMP-9 levels were directly proportional to the IL-17A levels. The high-
est IL-17A expression was found in the largest lesions and the lesions with the longest
duration. These lesions are often also associated with a continuous influx of neutrophils
and tissue damage and remodeling due to the production of ROS and metalloproteases
and this could explain the correlation found between IL-17A and MMP-9 in mycetoma
lesions.
Introduction
Mycetoma is a common neglected disease, endemic in many tropical and subtropical areas [1].
It is a chronic granulomatous inflammatory disease, which usually spreads to involve the skin,
deep structures and leads to massive deformities, disabilities and deformities [2]. It usually
affects young adults and children, is commonly seen in farmers and workers dealing with the
soil [3, 4] and has many negative impacts on patients, families and community [5, 6].
Fifty-Six different microorganisms of both bacterial (actinomycetoma) and fungal origin
(eumycetoma), can cause mycetoma [7–9]. In Sudan, the most commonly encountered micro-
organisms are the fungus Madurella mycetomatis and the bacteria Streptomyces somaliensis,
Actinomadura madurae and Actinomadura pelletieri. Clinically, mycetoma presents as a slow
growing tumour-like soft tissue mass that gradually increases in size. With time, multiple
sinuses develop, and eventually, they drain purulent and seropurulent discharge that contains
grains [10, 11]. These grains which are characteristic of mycetoma are of different colours,
sizes and consistency depending on the causative organisms [12, 13]. M. mycetomatis produces
black grains, S. somaliensis forms yellow grains and A. pelletieri forms red grains.
Although these micro-organisms form grains of different color and consistency, the tissue-
reaction surrounding these grains are quite similar. In general, the grains are surrounded by
three zones of inflammatory cells. The innermost zone, zone 1, consists mainly of neutrophils
[14]. The following zone, zone 2 consists mainly of macrophages and the outermost zone,
zone 3, contains lymphocytes and plasma cells [15]. Furthermore, encapsulation by collagen
fibers was also demonstrated [16]. Although the inflammation reaction between eumycetoma
and actinomycetoma is similar, there are some differences. The number of CD8+ lymphocytes
and macrophages was higher in actinomycetoma lesions than in eumycetoma lesions [17]. In
order to find some clues about the type of immune reaction needed to establish a mycetoma
granuloma, several immunological studies were carried out to address these aspects. Few stud-
ies have reported the role of cellular immunity in human [18]. Furthermore, El Hassan and
colleagues determined the cytokine profile in the inflammatory reaction surrounding S. soma-
liensis lesions [15]. Th2 cytokines interleukin (IL)-4 and IL-10 were found to be mainly
expressed while Th1 cytokine interferon γ (INF-γ) was only expressed in 1 out of 3 patients
[15], moreover, Mhmoud and her associates determined the association between Th2 cytokine
namely IL-10 in the granuloma caused by M. mycetomatis. Their results showed that IL-10 was
expressed in all zones surrounding the grains of M. mycetomatis [19]. At the time of that study,
the authors mainly focused on the Th1 and Th2 response, the Th17 response was not investi-
gated. However, in the following years more insight was obtained in the Th17 response. The
Th17 response appeared to play an important role the subcutaneous fungal implantation
mycosis chromoblastomycosis [20], and in experimental Nocardia brasiliensis mycetoma in
mice [21]. Th17 cells are a unique subset of CD4+ T-cells and are characterized by production
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of interleukin-17 (IL-17) [22]. IL-17 is a family of six cytokines known as IL-17A till F [23]. IL-
17A coordinates the tissue inflammation through higher expression of pro inflammatory cyto-
kines [24] and activation of epithelial cells and fibroblasts [25, 26]. This in its turn results in
the release of interleukin 6 (IL-6), interleukin 8 (IL-8) and tumor necrosis factor alpha (TNFα)
in macrophages, fibroblasts, and endothelial cells which ultimately lead to pronounced neutro-
phil infiltration [27–31]. A phenomenon also seen in mycetoma lesions. IL-17A then activates
the neutrophils to produce rapid oxygen species (ROS) in order to destroy the extracellular
micro-organism [32]. More IL-17A will also be produced to attract even more neutrophils to
the site of infection [32], which results in even a higher production of ROS. Unfortunately
ROS is not specific in killing micro-organisms and local tissue damage will also occur. To be
able to respond to this tissue damage, matrix metalloproteases (MMPs) will be up-regulated in
order to remodel the tissue matrix [33, 34]. IL-17 is known to up-regulate of matrixmetallopro-
tease-2 (MMP-2) and MMP-9, both responsible for the formation of collagen capsules [35,
36]. Therefore it was not surprising that also in neutrophilic skin conditions such as mucosal
leishmaniasis [37] and amicrobial pustulosis of the folds [38], a correlation between IL-17 and
MMP-9 expression seemed to be present. Also in mycetoma lesions both MMP-2 and MMP-9
are expressed at the site of infection [16], however to date there is no data indicating whether a
Th17 response plays a role in the mycetoma granuloma formation and if there is a correlation
between IL-17A expression and MMP expression in mycetoma lesions. To address this ques-
tion, as a proof of principle, we assessed the IL-17A and MMP-9 expression in the mycetoma
granuloma caused by M. mycetomatis, S. somaliensis and A. pelletieri using an immunohisto-
chemical (IHC) appraoch and correlated their expression levels with the clinical characteristics
of the patients.
Materials and methods
This descriptive study was conducted at the Mycetoma Research Centre, Soba University Hos-
pital, University of Khartoum, Khartoum, Sudan. The study included 100 patients with differ-
ent confirmed types of mycetoma. The diagnosis was confirmed by meticulous clinical
examinations, culture of grains and histopathological examination of material obtained by a
surgical biopsy. Surgical biopsies from these patients were fixed in 10% formalin for 24 hours,
and paraffin blocks were prepared. All sections were stained with haematoxylin and eosin
(H&E). The mycetoma causative organisms in the studied patients were M. mycetomatis
(n = 80), S. somaliensis (n = 12) and A. pelletierii (n = 8), a representation of the distribution of
causative agents normally seen in the Mycetoma Research Centre.
Collagen fibers detection
Collagen fibers were detected in tissue sections by staining them in Weigert’s iron hematoxylin
working solution for 10 minutes. After rinsing in running warm tap water for 10 minutes and
washing in distilled water they were stained with scarlet-acid fuchsine solution for 10–15 min-
utes and washed in distilled water. They were differentiated in phosphomolybdic-phospho-
tungstic acid solution for 10–15 minutes or until collagen was not red. Sections were
transferred directly, without rinse, to aniline blue solution and stained for 5–10 minutes. They
were rinsed briefly in distilled water and differentiated in 1% acetic acid solution for 2–5
minutes.
They were washed in distilled water, dehydrated very quickly through 95% ethyl alcohol,
absolute ethyl alcohol and cleared in xylene. They were mounted with resinous mounting
medium [39].
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Immunohistochemical staining
Immunohistochemical staining was used to determine the MMP-9 and IL-17 expression
around the grains of different mycetoma causatives agents. The deparaffinized tissue sections
were mounted onto 3-aminopropyltriethoxysilane coated slides. Antigen retrieval was per-
formed by incubating the sections in citrate buffer solution in water bath at 96˚C for ten min-
utes as described previously [39].
After antigen retrieval, the tissue sections were rinsed first in distilled water and then with
Tris buffer saline (TBS), followed by treatment with peroxidase block (3% hydrogen peroxide
in methyl alcohol) for 15 min to quench endogenous peroxidase activity. The slides were
then placed in a humid chamber. Then, the slides were drained and rinsed in two successive
changes of Tris buffer (wash buffer), for five mins each. Non-specific protein-protein interac-
tions were blocked by treating and incubating the tissue sections with the power block (casein
in phosphate buffered saline) for 10 minutes in a humid chamber. The remaining solution
was drained from the slides. For staining MMP-9, the sections were then incubated in the
ready to use primary antibody (MMP-9); rabbit monoclonal antibody (class IgG, clone
EP1255Y, BioGenex) at room temperature in the humid chamber for 30 mins. The remaining
solution was drained from the slides and rinsed in two changes of Tris buffer saline (washing
buffer) as mentioned earlier. Sections were then treated with a reagent for enhancing the
staining for 30 min, followed by rinsing in two changes of Tris buffer. Sections were then
incubated with multilink secondary antibody solution (EPOS) for 30 min, followed by rinsing
with wash buffer and treated with HRP label (HRP-conjugated streptavidin) for 30 min. For
staining IL-17, sections were incubated with primary antibody abcam ab79056 (IL-17; 1/100
in PBS +10% serum) for 14 hours at 4˚C after which, the sections were washed in washing
buffer for four times. A Biotin-conjugated goat anti-rabbit was used as the secondary anti-
body; the sections were incubated for ten mins, followed by rinsing in the washing buffer for
four times. Then the sections were stained with Streptavidin-Peroxidase and incubated for 10
minutes at room temperature, followed by rinsing four times in buffer. To visualize the bind-
ing of the antibodies, sections were treated with DAB chromogen/substrate 3, 3-DAB chro-
mogen/H2O2/substrate buffer solution (1 ml of DAB buffer mixed with 2 drops of DAB
chromogen in a mixing vial and allowed to stand for about 10 min), covered with drops of
chromogen DAB buffer solution, and allowed to stand in the humid chamber for 10 min.
During this period, brown staining was visualised with varying intensity on different sections.
Then, the slides were rinsed first in distilled water followed by running tap water. The sections
were then counterstained with Mayer’s hematoxylin solution for 5 minutes, rinsed in running
tap water, and dehydrated, cleared and mounted with dibutyl phthalate and xylene (DPX).
Lymphoid tissue sections were used as positive controls while specimens that were treated as
above except for the fact that the primary antibody was omitted and were used as negative
controls.
IL-17 and MMP-9 expression scoring system
To determine the IL-17 and MMP-9 roles in the mycetoma granuloma, a scoring system was
designed to grade the expression. The tissue sections which didn’t express MMP-9 and IL-17
were considered negative. Positive tissue sections were further classified using a two-level scor-
ing system; the quantity and intensity staining systems. The quantity staining corresponded to
the percentage of immunoreactive cells and it is as follows, No staining = 0, 1–10% of cells = 1,
11–50% of cells = 2, 51–70% of cells = 3 and>70% = 4.
The intensity staining score was ranged as follows: No staining = 0, weak staining = 1, mod-
erate staining = 2, and strong staining = 3.
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Both the staining quantity and intensity were determined by the total Immunohistochemi-
cal (IHC) score. It ranged from 0 to 12, IHC score ranged between 0 to 4 were considered as
low levels of expression while score from >4 to 12 were high levels of expression [40, 41].
The studied sections were interpreted by three independent expert pathologists. Photomi-
crographs were taken with Olympus SP-350 camera (Olympus Imaging America Inc., Center
Valley, Pennsylvania, United States).
Statistical analysis
The obtained data were processed using the Statistical Package for Social Sciences (SPSS ver-
sion 11). Chi-square, ANOVA tests were used for data analysis to determine if IL-17A or
MMP-9 expression was linked to causative agent, gender, lesion size or duration of the disease.
To determine if IL-17A and MMP-9 expression was correlated Pearson correlation test was
used. In general, p values less than 0.05 were considered statistically significant. All statistical
analysis was performed using the statistical package SPSS11.0 (SPSS Incorporated, Chicago).
Ethical statement
Study ethical clearance was obtained from Soba University Hospital Ethical Committee. Indi-
vidual patient’s informed consent proved to be not necessary for this study as the surgical
biopsies were part of routine patients’ management. All data anonymized before analyzed.
Results
The current study included 100 patients with confirmed mycetoma. All patients were on treat-
ment. There were eighty-three males and 17 females; their ages ranged between seven and 61
years with a mean age of 26.9± 10.9 years. The disease duration ranged between one and 12
years with a mean duration of 3.7± 2.8 years. The lesion sizes were small (<5cm) (14%), mod-
erate (5-10cm) (62%), and massive (24%) (>10cm). The most common site of the infection
was the foot (56%), right ankle (19%), hand (12%), leg (7%) and the least common site was the
big toe (6%). (Table 1). Out of these 100 patients, 80 patients had mycetoma caused by M.
mycetomatis, 12 patients had mycetoma caused by S. somalienisis and 8 patients had mycetoma
caused by A. pelletieri (Table 1). As can be seen in Fig 1, for all three species the inflammation
surrounding the mycetoma grain was composed of three zones as described in literature
Table 1. The clinical characteristics of the studied population.
Characteristics No. (%)
Gender
Male 83%
Female 17%
Lesion Size
Small (Less than 5 cm) 14%
Moderate (5–10 cm) 62%
Massive (more than 10 cm) 24%
Site
Foot 56%
Right ankle 19%
Hand 12%
Leg 7%
Big toe 6%
https://doi.org/10.1371/journal.pntd.0007351.t001
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Fig 1. Hematoxylin and eosin stained sections demonstrating the grains (G) of A; S. somaliensis, B; A. pelletieri
and C; M. mycetomatis, grains highlighted different inflammatory zones, Zone 1, 2 and 3 that surrounding the
grains (G) (H and E, X 10). This figure is composed of representative pictures from single patients. Differences among
individual patients were noted, however we chose pictures which correlated with the majority of each group of
patients.
https://doi.org/10.1371/journal.pntd.0007351.g001
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(Fig 1). Furthermore, as can be seen in the Masson Trichrome stained sections, both eumyce-
toma and actinomycetoma grains were encapsulated by collagen fibres. For eumycetoma these
collagen fibers usually presented as thin rings more closely to the grain and were then followed
by dense collagen bundles at the periphery of the ring. This differed from the collagen fibres
seen in actinomycetoma lesions. In these lesions, the bacterial grain was usually only sur-
rounded by thin collagen fibers, no dense collagen bundles were noted. (Fig 2).
IL-17A is mainly expressed in zones I and II of large mycetoma lesions
As can be seen in Fig 3, IL-17A was expressed in the cells surrounding the grains. Since the
inflammatory reaction surrounding the mycetoma grains differs per zone it was also assessed
if the IL-17A expression differed per inflammation zone. For all three causative agents, the
highest expression was noted in zones I and II, lower expression was noted in zone III (Fig 3).
IL-17A expression was noticed within the cytoplasm of neutrophils, macrophages and Lym-
phocyte cells. Strikingly, slides in which a high expression of IL-17A was seen, angiogenesis
were more prevalent than in slides were this was not the case. To assess if different IL-17A
expression patterns were seen with the different causative agents, our results showed that a sig-
nificant difference in IL-17A expression between the different causative agents was seen (Krus-
kal-Wallis Test, p = 0.009). No differences in IL-17A expression were noted between males
and females. However, a significant higher expression was found in large lesions compared to
small lesions (p = 0.012), or in lesions with a longer disease duration (p = 0.020) (Table 2).
MMP-9 is mainly expressed in zones II and III surrounding the mycetoma
grain
MMP-9 expression was detected as brown cytoplasmic stain within the cells. It was found to
be mainly expressed in Zones II and III surrounding the mycetoma grain (Fig 4). Only limited
expression was found in Zone I. Stromal expression (i.e. connective tissue parenchymal) of
MMP-9 was negative in all the areas which contained thick bundles of collagen fibers. As can
be seen in Fig 5, MMP-9 was more highly expressed in A. pelletierii and S. somaliensis biopsies
compared to M. mycetomatis (Kruskal-Wallis Test, p< 0.0001). No difference in MMP-9
expression was noted between males and females. However, a significant higher MMP-9
expression was found in lesions with a longer disease duration (p< 0.0001), on other hand no
significant higher MMP-9 expression was found in large lesions compared to small lesions
(Table 3).
Correlation between IL-17A expression and MMP-9 expression and
collagen deposition
To determine if there was a correlation between IL-17A expression and MMP-9 expression the
expression levels for each of the samples were plotted. As can be seen in Fig 6, there was a cor-
relation between IL-17A expression and MMP-9 expression (p< 0.0001).
Discussion
The immunopathological mechanisms involved in the chronic granulomatous inflammation
reaction in mycetoma are not well understood but evolving body of evidence suggested that
cytokines play a critical role in granuloma formations. Both Th1 and Th2 cytokines were
observed to be expressed in the mycetoma granuloma and the Th2 cytokines appeared to be
more dominant expressed [15, 19]. In the current study we demonstrated that also the Th17
signature cytokine, IL-17A was expressed in the mycetoma granuloma of different mycetoma
Interleukin-17 and matrix metalloprotease-9 expression in the mycetoma granuloma
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Fig 2. Collagen deposition around different mycetoma causatives agent; in this figure a representative picture of the
A. pelletieri grain insight the subcutaneous tissue from one particular patient is shown. In panel A, a HE staining is
performed. In panel B, a Masson trichrome staining of the same area is shown. As is seen on this slide, collagen (coloured
blue) is mainly seen within zone 2 as a fine thin bundles that surrounded the grains. In panel C, a HE staining is performed
from patient with S. somaliensis; and D, collagen fibers is mainly seen within zone 2 as a fine thin bundles that surrounded
the grains; in Panels E and F showed a collagen fibers in M. mycetomatis, with thick collagen bundles. This figure is
composed of representative pictures from single patients. Differences among individual patients were noted, however we
chose pictures which correlated with the majority of each group of patients.
https://doi.org/10.1371/journal.pntd.0007351.g002
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Fig 3. IL-17A expression in M. mycetomatis (A), S. somaliensis (B) and A. pelletieri (C) lesions. IL-17A staining was
seen as a brown cytoplasmic staining in cells. This figure is composed of representative pictures from single patients.
Differences among individual patients were noted, however we chose pictures which correlated with the majority of
each group of patients.
https://doi.org/10.1371/journal.pntd.0007351.g003
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causative agents including M. mycetomatis, S. somaliensis and A. pelletieri. In eumycetoma
caused by M. mycetomatis it was found to be mainly expressed in zones I and II, lower expres-
sion was noted in zone III. A similar expression pattern was found for actinomycetoma grains
caused by S. somaliensis and A. pelletierii. To find IL-17A expressed in polymorphonuclear
cells surrounding fungal or actinomycete infections is not unique and it was also described in
granulomas in paracoccidioidomycosis [42], and in Mycobacterium bovis infections [43] and
even in mycetoma lesions caused by Nocardia brasiliensis [21], and Phialophora richardsiae
[44]. In the M. bovis infection model it was demonstrated that IL-17A deficient mice showed
impaired granuloma formation, indicating the importance of IL-17A in establishing granulo-
ma’s around actinomycete infections [45]. However for M. bovis IL-17A was mainly expressed
in the early stages of the disease [43]. Also in experimental Nocardia brasiliensis mycetoma, IL-
17A was found to be increased mainly at the beginning of the infection [21], at the time the N.
brasiliensis mycetoma granuloma is formed. As with M. mycetomatis, A. pelletieri and S. soma-
liensis mycetoma, the N. brasiliensis granuloma is characterized by neutrophils and the high
expression of IL-17A in the beginning of the infection could be responsible for the recruitment
of neutrophils [21].
One of the shortcommings of our study is that we were able to look at expression at a fixed
moment of time, a time point in which the mycetoma granuloma was already formed. With
immunohistochemistry we therefore were only able to demonstrate the presence of IL-17A
and MMP-9, not the time point when they were formed. It is therefore impossible to deter-
mine the precise function of IL-17A and MMp-9 in the formation of the mycetoma granu-
loma, we could only determine their presence. However, taken this in mind, we did found
differences in the expression level of IL-17A in the different lesions. The highest IL-17A
expression was found in the largest lesions and the lesions with the longest duration. One
explanation could be that these might also be the most aggressive lesions and that the contin-
ues expression of IL-17A results in the massive lesions. Indeed, in gastric cancer higher IL-17A
expression was also found in more aggressive and larger tumours [46]. Continues IL-17A
expression, will result in a continues influx of neutrophils at the site of infection and a continu-
ous influx of tissue damage and remodeling due to the production of ROS and metallopro-
teases. However, since in our study we were only to look at a single time point per patient, it is
impossible to say if IL-17A is continuously expressed and how it exactly interacts with other
cytokines and chemokines within mycetoma lesions. Further studies are needed to investigate
the role of the different cytokines and their interplay in more detail.
If indeed tissue damage plays an important role in the formation of the mycetoma granu-
loma a role of IL-17A could be proposed. IL-17A is known to up-regulate MMP-9 expression,
Table 2. Correlations between the IL-17 expression and the patient’s clinical data.
Characteristics IL 17 expression Total p value
Negative Low expression Highly expressed
Gender Male 11 26 46 83 0.765
Female 2 4 11 17
Lesion Size Less than 5 cm 2 3 10 15 0.012
5–10 cm 11 23 29 63
More than 10 cm 0 4 18 22
Duration Less than 3 years 3 10 28 41 0.020
3 to 6 years 10 20 24 54
More than 6 years 0 0 5 5
https://doi.org/10.1371/journal.pntd.0007351.t002
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Fig 4. MMP-9 expression in M. mycetomatis (A), S. somaliensis (B) and A. pelletieri (C). Stromal expression (i.e.
connective tissue parenchymal) of MMP-9 was negative in all the areas which contained thick bundles of collagen
fibers (arrow head) (X 10). This figure is composed of representative pictures from single patients. Differences among
individual patients were noted, however we chose pictures which correlated with the majority of each group of
patients.
https://doi.org/10.1371/journal.pntd.0007351.g004
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Fig 5. Showed the expression of IL-17 within tissue sections; A: IL- 17 was expressed in T-lymphocyte cells and
neutrophils. B; in giant cells, C; Stromal cells were noticed to expressed the IL 17. This figure is composed of
representative pictures from single patients. Differences among individual patients were noted, however we chose
pictures which correlated with the majority of each group of patients.
https://doi.org/10.1371/journal.pntd.0007351.g005
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and to increase the level of active MMP-9 [47–49]. In our study we also demonstrate the posi-
tive correlation between IL-17A and MMP-9 expression.
However, the presence of any MMP at the site of infection does not necessarily mean that
the MMP is activated. Geneugelijk and colleagues demonstrated the presence of both MMP-2
and MMP-9 in eumycetoma lesions caused by M. mycetomatis. Although MMP-2 and MMP-9
were both found to be expressed at the site of infection, only in 36% of patients with M. myce-
tomatis the activated form of MMP-9 was present. The activated form of MMP-2 was
completely absent [16]. Unlike IL-17A expression, we did found differences in MMP-9 expres-
sion between M. mycetomatis and the actinomycetoma lesions A. pelletierii and S. somaliensis.
MMP-9 was expressed in larger quantities in A. pelletierii and S. somaliensis lesions compared
to M. mycetomatis. This correlated also with the smaller collagen capsules encountered in A.
Table 3. Correlations between the MMP-9 expression and the patient’s clinical data.
Characteristics MMP 9 expression Total p value
Negative Low expression Highly expressed
Gender Male 7 60 16 83 0.192
Female 4 9 4 17
Lesion Size Less than 5 cm 3 8 4 15 0.053
5–10 cm 8 46 9 63
More than 10 cm 0 15 7 22
Duration Less than 3 years 7 22 12 41 <0.0001
3 to 6 years 4 47 3 54
More than 6 years 0 0 5 5
https://doi.org/10.1371/journal.pntd.0007351.t003
Fig 6. Correlation between IL-17A expression intensity and MMP-9 expression intensity, r = 0.8887, p value
<0.0001.
https://doi.org/10.1371/journal.pntd.0007351.g006
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pelletieri and S. somaliensis compared with M. mycetomatis. The difference could also be due
to the differences in treatment. All M. mycetomatis patients were on itraconazole treatment at
the time the biopsy was performed. In a paraccocidiomycosis mouse model it was demon-
strated that itraconazole treatment resulted in a significant reduction of MMP-1α, MMP-8
and MMP-13 expression, while an increase in expression was noted for MMP-12 and MMP-
14 [49]. MMP-9 was not measured in that study; however itraconazole treatment could have
also influenced the expression of MMP-9. Furthermore, in a study conducted by Yuan and his
associates they investigated the expression of MMPs notably MMP-8, -9, -10, -12, -13, -1 and
tissue inhibitors of metalloproteinases (TIMPs) during the inception and progression of exper-
imental keratomycosis due to Candida albicans using BALB/c mice. Their results showed that
Mock-infected corneas demonstrated moderate epithelial staining and minor stromal staining
for MMP-8, -9, -13, and TIMP-1 while corneas from infected animals had increased staining
for these proteins throughout the epithelium and stroma [50].
In summary, the results obtained in the present study demonstrated that IL-17A and
MMP-9 were expressed in the granuloma of different mycetoma causative agents and that the
expression of IL-17A was more extensively in larger leasions and lesions with a longer disease
duration. We also deomonstrated a positive correlation between IL-17A expression levels and
MMP-9 expression levels. However, since we only demonstrated expression, more studies are
needed to determine the roles of IL-17A and MMP-9 in the granuloma formation and to pro-
vide further insights in the mycetoma immunopathogenesis. The observations presented here
are the first step and indicate tha IL-17A and MMP-9 are present within the grain. The func-
tions of IL-17A and MMP-9 in the formation of the grain will be studied in future studies.
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